Transcription of Public Assessment Report Decentralised Procedure
{{id}} {{{paragraph}}}
Example: stock market
Public Assessment Report Decentralised Procedure
Public Assessment Report Decentralised Procedure dexamethasone MG/ML SOLUTION FOR. INJECTION. ( dexamethasone sodium phosphate). Procedure No: UK/H/5163/001/DC. UK Licence No: PL 28176/0115. Strides Arcolab International Limited PAR dexamethasone mg/ml Solution for Injection UK/H/5163/001/DC. LAY SUMMARY. dexamethasone mg/ml Solution for Injection ( dexamethasone sodium phosphate). This is a summary of the Public Assessment Report (PAR) for dexamethasone mg/ml Solution for Injection (PL 28176/0115). It explains how dexamethasone mg/ml Solution for Injection was assessed and its authorisation recommended as well as its conditions of use. It is not intended to provide practical advice on how to use dexamethasone mg/ml Solution for Injection. For practical information about using dexamethasone mg/ml Solution for Injection, patients should read the package leaflet or contact their doctor or pharmacist. What is dexamethasone mg/ml Solution for Injection and what is it used for?
What are the benefits and risks of Dexamethasone 3.3 mg/ml Solution for Injection? Because Dexamethasone 3.3 mg/ml Solution for Injection is a generic medicine and is comparable to the
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: